RTTNews | Dec 27, 2021 08:02AM EST

08:02 Monday, December 27, 2021 (RTTNews) - I-Mab Unveils IND Approval From China NMPA For Phase 2 Trial Of Enoblituzumab With Pembrolizumab In Solid Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved